The Short-Term Impact of Botulinum Neurotoxin-A on Muscle Morphology and Gait in Children with Spastic Cerebral Palsy

N Peeters, E Papageorgiou, B Hanssen… - Toxins, 2022 - mdpi.com
Children with spastic cerebral palsy (SCP) are often treated with intramuscular Botulinum
Neurotoxin type-A (BoNT-A). Recent studies demonstrated BoNT-A-induced muscle atrophy …
被引用次数：4 相关文章

The short-term impact of botulinum neurotoxin-A on muscle morphology and gait in children with spastic cerebral palsy

N Peeters, E Papageorgiou, B Hanssen… - TOXINS, 2022 - biblio.ugent.be
Children with spastic cerebral palsy (SCP) are often treated with intramuscular Botulinum
Neurotoxin type-A (BoNT-A). Recent studies demonstrated BoNT-A-induced muscle atrophy …

The Short-Term Impact of Botulinum Neurotoxin-A on Muscle Morphology and Gait in Children with Spastic Cerebral Palsy

N Peeters, E Papageorgiou, B Hanssen… - Toxins, 2022 - search.proquest.com
Children with spastic cerebral palsy (SCP) are often treated with intramuscular Botulinum
Neurotoxin type-A (BoNT-A). Recent studies demonstrated BoNT-A-induced muscle atrophy …

The Short-Term Impact of Botulinum Neurotoxin-A on Muscle Morphology and Gait in Children with Spastic Cerebral Palsy.

N Peeters, E Papageorgiou, B Hanssen… - Toxins, 2022 - europepmc.org
Children with spastic cerebral palsy (SCP) are often treated with intramuscular Botulinum
Neurotoxin type-A (BoNT-A). Recent studies demonstrated BoNT-A-induced muscle atrophy …
[PDF] kuleuven.be

[PDF][PDF] The Short-Term Impact of Botulinum Neurotoxin-A on Muscle Morphology and Gait in Children with Spastic Cerebral Palsy

N Peeters, E Papageorgiou, B Hanssen… - knee, 2022 - lirias.kuleuven.be
Children with spastic cerebral palsy (SCP) are often treated with intramuscular Botulinum
Neurotoxin type-A (BoNT-A). Recent studies demonstrated BoNT-A-induced muscle atrophy …

The Short-Term Impact of Botulinum Neurotoxin-A on Muscle Morphology and Gait in Children with Spastic Cerebral Palsy.

N Peeters, E Papageorgiou, B Hanssen… - …, 2022 - search.ebscohost.com
Children with spastic cerebral palsy (SCP) are often treated with intramuscular Botulinum
Neurotoxin type-A (BoNT-A). Recent studies demonstrated BoNT-A-induced muscle atrophy …

The Short-Term Impact of Botulinum Neurotoxin-A on Muscle Morphology and Gait in Children with Spastic Cerebral Palsy

N Peeters, E Papageorgiou, B Hanssen… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Children with spastic cerebral palsy (SCP) are often treated with intramuscular Botulinum
Neurotoxin type-A (BoNT-A). Recent studies demonstrated BoNT-A-induced muscle atrophy …
[HTML] nih.gov

[HTML][HTML] The Short-Term Impact of Botulinum Neurotoxin-A on Muscle Morphology and Gait in Children with Spastic Cerebral Palsy

N Peeters, E Papageorgiou, B Hanssen… - Toxins, 2022 - ncbi.nlm.nih.gov
Children with spastic cerebral palsy (SCP) are often treated with intramuscular Botulinum
Neurotoxin type-A (BoNT-A). Recent studies demonstrated BoNT-A-induced muscle atrophy …

The Short-Term Impact of Botulinum Neurotoxin-A on Muscle Morphology and Gait in Children with Spastic Cerebral Palsy.

N Peeters, E Papageorgiou, B Hanssen… - Toxins (Basel …, 2022 - lirias.kuleuven.be
Children with spastic cerebral palsy (SCP) are often treated with intramuscular Botulinum
Neurotoxin type-A (BoNT-A). Recent studies demonstrated BoNT-A-induced muscle atrophy …

The Short-Term Impact of Botulinum Neurotoxin-A on Muscle Morphology and Gait in Children with Spastic Cerebral Palsy.

N Peeters, E Papageorgiou, B Hanssen… - Toxins, 2022 - europepmc.org
Children with spastic cerebral palsy (SCP) are often treated with intramuscular Botulinum
Neurotoxin type-A (BoNT-A). Recent studies demonstrated BoNT-A-induced muscle atrophy …